The present study aims to investigate the effects of the 10-Series of Structural Integration on chest wall expansion in patients with stable COPD using a randomized controlled trial design. Participants receiving Structural Integration in addition to conventional pulmonary rehabilitation will be compared with those receiving conventional pulmonary rehabilitation alone. Chest wall expansion will serve as the primary outcome, while pulmonary function, dyspnea, functional exercise capacity, and quality of life may be evaluated as secondary outcomes.
Clinically diagnosed stable COPD according to GOLD criteria
GOLD stage II or III
No acute exacerbation within the previous four weeks
Able to ambulate independently
Severe cardiovascular disease contraindicating exercise
Recent thoracic or abdominal surgery (<6 months)
Rib fractures or severe chest wall deformity
Neurological disorders affecting mobility
Parallel
Structural Integration with Conventional Pulmonary Rehabilitation
Other intervention* Conventional pulmonary rehabilitation. * The complete 10-Series of Structural Integration, delivered by a certified Structural Integration practitioner/physiotherapist.
Pulmonary Rehabilitation only
Other interventionParticipants receive only the conventional pulmonary rehabilitation program.
Chest Wall Expansion
Chest wall expansion will be measured using a flexible measuring tape at: * Axillary level * Xiphoid level * Lower thoracic level (10th rib) Measurements will be taken during maximal inspiration and maximal expiration. The difference (in centimeters) will be recorded. Three readings will be obtained at each level, and the average value will be used for analysis.
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: